The YIPP (tyrosine-isoleucine-proline-proline, amino acids 319 -322) motif within the C-terminal part of the human AT 1 receptor is associated with angiotensin II (AII)-induced activation of the Jak-STAT pathway and phospholipase Cg1 phosphorylation. We report here that mutations of the YIPP motif strongly affect ligand-binding to the receptor. We analysed AT 1 receptors of the wild type (WT) and 11 mutants with a FLAG-epitope-tag within their C-terminal portion. Mutations of the ''P -P'' amino acid sequence of this motif decreased both AII binding and the AII-induced intracellular Ca 2 + transients. Mutant and WT receptors were expressed equally in the cell membrane and were localized within the plasma membrane. These results suggest that the ''P -P'' amino acid sequence within the YIPP motif is important for AII binding to the AT 1 receptor. D
Introduction
Angiotensin II (AII), the primary mediator of the reninangiotensin system, plays important roles in controlling both blood pressure and the electrolyte and body fluid balance [1, 2] . Two AII-receptor subtypes, type 1 (AT 1 receptor) and type 2 (AT 2 receptor), have been described, cloned and characterized [3] . The AT 1 receptor is responsible for the well-known effects of AII, such as vasoconstriction and control of water intake and cellular proliferation [4] , while the AT 2 receptor has actions antagonistic to those of the AT 1 receptor [5] . AT 1 receptors have seven transmembrane domains ( Fig. 1A) and belong to the superfamily of guanine-nucleotide-binding protein (G-protein)-coupled receptors [6] . Stimulation of this receptor activates phospholipase C (PLC) h1 and PLCg1, which generate inositol 1,4,5triphosphate (IP 3 ) and diacyl glycerol (DG). Then, IP 3 increases the intracellular Ca 2 + concentration and DG activates protein kinase C (PKC) [5, 7] . In addition, it has been also reported that AII activates both Janus kinase (Jak) 2 and mitogen-activated protein (MAP) kinase [8, 9] . The AT 1 receptor activates Jak2 kinase not through activation of G-protein, but through the YIPP (tyrosine-isoleucine-proline-proline amino acid residues) motif situated within the carboxyl-terminal region of the receptor (C-terminal, Fig.  1A ) [10] . In fact, the AT 1 receptor interacts with PLCg1 via the YIPP motif [11] . The relationship between the AT 1 receptor and the PLC family is still unclear due to discrepancies among the results in past reports [12] . Nevertheless, these reports did make clear that this motif was important for signal transduction by the AT 1 receptor [10, 11] . Recently, AbdAlla et al. [13] reported that the human AT 1 receptor and bradykinin B 2 receptor can form stable heterodimers and that the heterodimerization enhances AT 1 -receptor signalling. Thus, this report demonstrated the possibility of relationships between the AT 1 receptor and other factors.
We hypothesized that the YIPP motif performed a regulatory function in ligand binding as well as having a relationship to signal transduction. Therefore, to examine the relationship between the YIPP motif and the ligand-binding function, we made the 11 mutants of the YIPP motif shown in Fig. 1B and investigated whether each mutant receptor could influence the binding of 125 I-AII and the AII-induced intracellular Ca 2 + mobilization, and we examined the expression and localization of the receptors in COS-7 cells.
Materials and methods

Materials
KRH-594, a selective AT 1 receptor antagonist [14] , was synthesized by Kissei Pharmaceutical Co. Ltd. Human AII was purchased from Peptide Institute. 125 I-AII (specific activity 2200 Ci/mmol) and 3 H-AII (42.5 Ci/mmol) were purchased from Dupont/NEN. pCAGGS, a mammalian expression vector [15] , was kindly supplied by Prof. Izumi Saito (Institute of Medical Science, University of Tokyo).
AT 1 receptor cloning
Reverse transcription PCR (RT-PCR) of the human AT 1 receptor was carried out using a GeneAmp RT-PCR kit (Perkin-Elmer). First-strand cDNA was synthesized from human placenta polyA + RNA (Clontech), then amplified according to the manufacturer's instructions except that LA-Taq polymerase (Takara) was used instead of Ampli-Taq polymerase. The AT 1 receptor cloning primers were: upstream, 5V -TGTTTGCAACAAATTCGACC-3V ; downstream, 5V -AGGTTTCGAACATGTCACTC-3V . The PCR products were purified and subcloned into pCR2.1 (Invitrogen). The EcoRI-digested fragment of the human AT 1 receptor cDNA was ligated into a mammalian expression vector, pCAGGS, digested by EcoRI. The FLAG sequence (DYDDDK) was inserted into the C-terminal of the AT 1 receptor by PCR. The PCR primers were: upstream, 5V-CAG-TTTGTGCTTTCCATTAT-3V; downstream for the full-length AT 1 receptor-FLAG, 5V -CCTATGCATCCAGGGCATT-G G TCA CT TG TC GTC GT CG TC CTT GTA GTC CT-CAACCTCAAAACATGGTGCAGG-3V ; downstream for the 327STOP receptor; 5V -CCTATGCATCCAGGG-CATTGGTCACTTGTCGTCGTCGTCCTTGTAGTCG-GATTTGGCTTTTGGGGGAATAT-3V; the 319STOP receptor-FLAG, 5V-CCTATGCATCCAGGGCATTGGT- (TGA) in its C-terminal portion and also inserted into the EcoNI/BstXI site of human AT 1 receptor-pCAGGS.
C A C T T G T C G T C G T C G T C C T T G TA G T C T T T TA -GAAGCTGGAGAAAATATC-3V. This cDNA with the FLAG sequence was inserted upstream of the stop codon
Construction of AT 1 receptor mutants
To construct mutants of the 319 YIPP motif, we recombined AT 1 receptor cDNA into vector pkf18k (Takara). Then, the mutant clones (AIPP, FIPP, YAPP, YIAP, YIPA YIAA, YAAP, YAAA and FAAA) were made by site-directed mutagenesis using the Mutan-Super Express Km system (Takara) according to the manufacturer's instruction. The mutagenesis primers were: AIPP, 5V -GCTTCTAAAAGCCATTCCCC-CAAAAGCCAAATCC-3V ; FIPP, 5V -GCTTCTAAAA-TTCATTCCCCCAAAAGCCAAATCC-3V ; YAPP, 5V-GCTTCTAAAATATGCCCCCCCAAAAGCCAAATCC-3V; YIAP, 5V -GCTTCTAAAATATATTGCCCCAAAA-G C C A A AT C C -3 V ; YIPA, 5V -G C T T C TA A A ATA -TATTCCCGCCAAAGCCAAATCC-3V ; YAAP, 5V-GC-TTCTAAAATATGCCGCCCCAAAAGCCAAATCC-3V; YIAA, 5V -GCTTCTAAAATATATTGCCGCCAAAGC-CAAATCC-3V; YAAA, 5V -GCTTCTAAAATATGCCGC-CGCCAAAGCCAAATCC-3V; FAAA, 5V -GCTTCTAA-AATTTGCCGCCGCCAAAGCCAAATCC-3V . In addition, the 327th and 319th codons were changed to TGA (stop codon) by PCR. The amino acid sequences of the peptides used in this study are shown in Fig. 1B .
Cell culture and transfection with expression vectors
COS-7 (Riken cell bank) and 293T (GenHunter) cells were grown in DMEM supplemented with 10% fetal bovine serum (Equitech-Bio) and penicillin/streptomycin. COS-7 and 293T cells were transfected with the expression plasmids by use of an Effectene transfection reagent (Qiagen). Forty-eight hours after the transfection, the cells were used for experiments.
Radioligand-binding assay
Membranes from COS-7 and 293T cells transfected with vectors for AT 1 receptors were prepared as described elsewhere [16] . The binding assay buffer consisted of 50 mM Tris -HCl (pH 7.40), 125 mM NaCl, 6.5 mM MgCl 2 , 1 mM EDTA and 0.1% BSA. After pre-incubation with drug or vehicle for 2 h, the membranes were incubated with 125 I-AII or 3 H-AII at 25 jC for 90 min. Then, the assay mixtures were immediately passed through a glass filter, GF/B, and the filters were washed three times with ice-cold washing buffer [50 mM Tris -HCl (pH 7.40), 6.5 mM MgCl 2 ]. The residual radioactivity on the filters was counted by means of a gamma counter (COBRA5002; Packard) with 80% efficiency for 125 I-AII or by a liquid scintillation counter (liquid scintillation counter 1900CA; Packard) with 60% efficiency for 3 H-AII. Saturation-binding experiments were performed by incubating increasing concentrations of 125 I-AII (up to 1 nM) with 10 -30 Ag of crude membranes. Nonspecific binding of 125 I-AII and 3 H-AII was defined as the radioactivity bound to membranes in the presence of cold AII (10 AM). K d and B max values were calculated from the data obtained in the saturation experiments by a computer pro- Table 1 The K d and B max values of WT and mutant (YIAP, YIPA, YAAP, FAAA and 319STOP) AT 1 gram, Prism (GraphPad). G-protein coupling to AT 1 receptors was evaluated by measuring the binding of 125 I-AII (0.1 nM) in the absence or presence of GTPgS (10 AM).
In vitro transcription/translation
The cDNAs encoding WT and 319STOP AT 1 receptors were inserted into EcoRI site of pCRII (Invitrogen). In vitro transcription and translation were performed using a TNT Coupled Reticulocyte Lysate System (Promega) and 35 S-methionine (Dupont/NEN) according to the manufacturer's instructions, the reaction mixture being separated by SDS-PAGE and detected using BAS2500 (FUJIFILM).
Western blot analysis
COS-7 cells for Western blot analysis were co-transfected with the expression plasmid of WT or mutant receptors and the expression control plasmid, pcDNA3.1D/V5-His/lacZ (Invitrogen). For whole-cell lysates, cells expressing AT 1 receptors were washed with phosphate-buffered saline (PBS) and lysed in ice-cold RIPA buffer containing a proteaseinhibitor cocktail (Sigma). The samples were incubated on ice for 30 min, then centrifuged at 12,000 Â g for 10 min at 4 jC. Supernatants were collected and cell membrane fractions prepared as described elsewhere [16] . Protein concentrations were measured using a BCA protein-assay kit (Pierce, Rockford, IL). Whole-cell lysates (30 Ag) or cell membranes (7 Ag) were separated by SDS-PAGE and transferred onto PVDF membranes. The membranes were probed with a 1:600 dilution of anti-FLAG M2 monoclonal antibody (Sigma) or a 1:2000 dilution of anti-h-galactosidase monoclonal antibody (Promega). FLAG-epitope-tagged AT 1 (FLAG-AT 1 ) receptors and h-galactosidase were detected with the aid of a 1:1000 dilution of alkaline-phosphataseconjugated anti-mouse IgG polyclonal antibody (Santa Cruz) and an Alkaline Phosphatase Conjugate Substrate Kit (Bio-Rad), respectively.
Immunostaining of cells
COS-7 cells were seeded on eight-well chamber slides coated with poly-D-lysine and transfected with WT or mutant (AIPP, FIPP, YAPP, YIAP, YIPA, YAAP, YIAA, YAAA, FAAA, 327STOP and 319STOP) FLAG-AT 1 receptors as described above. The cells were then fixed with 3.7% formaldehyde/PBS at room temperature for 15 min. After they had been washed three times with PBS, the cells were permeabilized with 0.1% Triton X-100 at room temperature for 30 min and then washed again three times. Human WT and mutant FLAG-AT 1 receptors were detected with anti-FLAG M2 monoclonal antibody and fluorescein isothiocyanate (FITC)-conjugated anti-mouse IgG polyclonal antibody (Santa Cruz). Immunostained cells were mounted using AntiFade light (Molecular Probes). Cells were observed under a Zeiss LSM-410 confocal laser-scanning microscope (Carl Zeiss) using a filter set consisting of excitation [488 nm] and emission [510 nm] filters.
Intracellular Ca 2+ mobilization
Intracellular Ca 2 + mobilization was measured by a method described elsewhere [17] , except that the duration of fura-2/AM (Wako) loading was extended from 1 to 2 h.
Statistical analysis
Data were analyzed using an unpaired Student's t-test, a P value of less than 0.05 being considered significant.
Results
Radioligand-binding assay
As shown in Fig. 2 , 125 I-AII bound to WT and mutant (YIAP, YIPA, YAAP, FAAA and 319STOP) FLAG-AT 1 receptors with the same mode except for the high maximum binding for the WT receptor in the saturation experiment and the presence of a very low affinity site only for the WT receptor. The K d values obtained for the WT, YIAP, YIPA, YAAP, FAAA and 319STOP FLAG-AT 1 receptors were 0.16, 0.65, 0.64, 0.58, 0.48 and 0.58 nM, respectively (Table  1) . There was no difference in the binding of 125 I-AII (0.1 nM) among the WT, AIPP and YAPP FLAG-AT 1 receptors (Fig. 3) . However, the binding of 125 I-AII was moderately reduced in the case of the FIPP and YIAP FLAG-AT 1 receptors and significantly reduced in the case of the YIAA, YAAA and FAAA and YIPA FLAG-AT 1 receptors (Fig. 3) . The extent of 125 I-AII (0.1 nM) binding to FLAG-tagged receptors (WT and mutant receptors) was the same as when human AT 1 receptors without the tag were used (data not shown). The results of 125 I-AII (0.1 nM) binding to WT and mutant AT 1 receptors expressed in 293T cells were no different from those obtained in COS-7 cells (data not shown). We also examined the binding of a high concentration of 3 H-AII (100 nM) to FLAG-AT 1 receptors in order to investigate whether the binding to each receptor (WT and mutant receptors) would be the same as when we used 0.1 nM 125 I-AII. A high concentration of 3 H-AII (100 nM) bound to AIPP, FIPP and YAPP FLAG-AT 1 receptors to the same extent as to the WT FLAG-AT 1 receptor (data not shown), whereas it was moderately bound to YIAP, YAPP and YIPA FLAG-AT 1 receptors (data not shown). The AII binding to YIAA, YAAA and FAAA FLAG-AT 1 receptors was significantly decreased when the high concentration of 3 H-AII was used (data not shown). These results indicate that high and low concentrations of AII bound to AT 1 receptors in a similar way.
We next studied the effect of GTPgS on the binding of AII to WT and mutant FLAG-AT 1 receptors, since the AT 1 receptor is coupled to GTP-binding protein.
GTPgS inhibited 125 I-AII-binding to WT, YAAP and 319STOP FLAG-AT 1 receptors (Fig. 4) . The inhibitions were not different between WT and mutant FLAG-AT 1 receptors.
In vitro transcription/translation and Western blot analysis
To investigate the possible reasons for the decreases in 125 I-AII (0.1 nM) binding to mutant FLAG AT 1 receptors, we studied the expression of each receptor. In vitro transcription and translation showed that the molecular size of the WT receptor was between 30 and 35 kDa (Fig. 5A) . However, the size of the 319STOP receptor was smaller than that of the WT receptor.
Western blot analysis showed that there was no significant difference between the expressions of WT and mutant (AIPP, FIPP, YAPP, YIAP, YIPA, YAAP, YIAA, YAAA and FAAA) FLAG-AT 1 receptors in COS-7 cell membranes ( Fig. 5B and C) or in whole cell lysates (data not shown). However, the expression of the 319STOP FLAG-AT 1 receptor in COS-7 cells was significantly weaker than that of the WT receptor (Fig. 5B) , while the expression of the 327STOP FLAG-AT 1 receptor in COS-7 cells showed a tendency to be weaker (Fig. 5B ). In addition, h-galactosidase was equally expressed in all lysates except the mock (Fig. 5B ). The bands for WT and mutant (AIPP, FIPP, YAPP, YIAP, YIPA, YAAP, YIAA, YAAA and FAAA) receptors were almost all the same size as for the WT receptor obtained by in vitro transcription and translation using rabbit reticulocytes (between 30 and 35 Fig. 6 . Confocal laser-scanning microscopy of WT and mutant FLAG-AT 1 receptors in COS-7 cells. Bar represents 40 Am. kDa, Fig. 5B ). These band sizes seemed to be smaller than the theoretical size of the AT 1 receptor (41 kDa). Because the membranes for Western blotting were the same samples as those used for the binding assay, these bands show intact receptors having the capability to bind ligand. These results show that all clones were equally transfected and that the receptors were stably expressed.
Localization of FLAG-AT 1 receptors
The cellular localizations of WT and mutant FLAG-AT 1 receptors were examined in transfected COS-7 cells by confocal laser-scanning microscopy. All the receptors were localized within the plasma membrane (Fig. 6) . No signal was detected in the mock cells ( Fig. 6 ).
Intracellular Ca 2+ mobilization
Intracellular Ca 2 + mobilization is the target of one of the main AT 1 receptor-mediated signal pathways. We investigated whether mutation of the YIPP motif influenced AIIinduced intracellular Ca 2 + mobilization. In fura2/AMloaded cells expressing WT FLAG-AT 1 receptors, exposure to AII (10 nM -10 AM) induced a rapid rise in intracellular Ca 2 + in a concentration-dependent manner (Fig. 7A ). In the cells expressing AIPP and YAPP FLAG-AT 1 receptors, the Ca 2 + transient induced by AII (100 nM, the concentration used in the radioligand-binding assay) was not different from that in cells expressing the WT FLAG-AT 1 receptor, but the magnitude of the transients was moderately suppressed in those expressing FIPP, YIAP, YAAP, YIPA, Fig. 7 . AII-induced rapid rises in intracellular Ca 2 + concentration. (A) Typical recording and concentration dependency of AII-induced peak Ca 2 + responses in COS-7 cells expressing WT FLAG-AT 1 receptor. Data are presented as the mean F S.E. from four experiments. (B) AII (100 nM)-induced peak Ca 2 + responses in WT and mutant FLAG-AT 1 receptors. Data are presented as the mean F S.E. from seven to eight experiments with no antagonist, or as the mean F S.E. from three to four experiments with 1 AM KRH-594 as an AT 1 receptor antagonist. # P < 0.05 vs. WT with no treatment; ## P < 0.01 05 vs. WT with no treatment; *P < 0.05 vs. corresponding ''no treatment''; **P < 0.01 vs. corresponding ''no treatment''.
327STOP and 319STOP FLAG-AT 1 receptors. AII induced only a weak transient in the case of YIAA, YAAA and FAAA FLAG-AT 1 receptors (Fig. 7B ). All transients were suppressed by pretreatment with 1 AM KRH-594, a selective AT 1 receptor antagonist.
Discussion
The effects and effective mechanisms of the AT 1 receptor, which is a G-protein-coupled receptor (GPCR), have been revealed in several previous reports [18 -21] . Most reports on the mechanisms of GPCR focused especially on the binding sites for ligands and/or the sites related to Gprotein.
We supposed there to be intracellular systems regulating the binding of ligand (AII) to the AT 1 receptor. In this study, we investigated the relationship between ligand-binding and the YIPP motif because this motif seems to be important for the activation of Jak2 and PLCg1 [10, 11] . We constructed several mutant receptors and concentrated on investigating the function of the YIPP motif on ligand binding and signalling.
In recent years, the signaling pathways that do not involve G-protein coupling in the AT 1 receptor have been reported [10] , as have the functions of the C-terminal region [10, 11, [22] [23] [24] . Thr 332 , Ser 335 , Thr 336 , Leu 337 and Ser 338 residues located within a hepta-peptide segment of the Cterminal domain of the same receptor form a motif with the important role of internalization of the AT 1 receptor [22] . In addition, agonist-induced phosphorylation of the rat AT 1A receptor is confined to an 11-amino-acid serine/threoninerich segment of its C-terminal cytoplasmic tail, thus implicating this region in the mechanisms underlying receptor internalization and desensitization [23] . The 312 YFL in the C-terminal region of this receptor is reportedly essential for the coupling and activation of Gq [24] . The YIPP motif of the AT 1 receptor, the target site in the present study, is concerned with the activation of the Jak/STAT pathway and PLCg1-AT 1 receptor interaction [10, 11] . Although the progress has been made in defining the functions of the intracellular C-terminal region of this receptor, there is still much to be elucidated.
The relationship between the YIPP motif and AII-binding to the AT 1 receptor has not yet been analysed precisely, because the C-terminal portion of the receptor is located within the cytoplasm. In order to clarify the relationship, we constructed 11 mutants of the AT 1 receptor. All the receptors were found to be localized within the plasma membrane. However, FAAA, YAAA, YIAA and YIPA AT 1 receptors showed significantly reduced AII binding. When ''P -P'' was changed to ''A -A'', 125 I-AII binding was dramatically decreased.
Our computer-assisted saturation analysis of 125 I-AII binding to the WT AT 1 receptor demonstrated that the saturation curves fitted a two-site model (K d of site 1: 0.16 nM; K d of site 2: 18 mM). Some reports have suggested two distinct AII-binding sites in the AT 1 receptor [25, 26] . But in this study the K d value for site 2 is extremely large and does not have a physiological meaning. In our mutant AT 1 receptors (YIAP, YIPA, YAAP, FAAA and 319STOP), optimal fitting of the saturation curves was as for a one-site model. Although the reason is unknown, the YIPP motif might be related to this phenomenon.
Since these AII-binding modes (one-site or two-site binding) were different, the K d value obtained for the WT AT 1 receptor could not be directly compared with those obtained for the mutant receptors. However, AII-binding affinity between WT and mutant receptors seemed to be almost the same, on the basis of the Scatchard plot (Fig. 2) . On the other hand, each mutant AT 1 receptor exhibited a decreased B max value. Therefore, ''P -P'' of amino acids within the YIPP motif may be important for AII-binding to AT 1 receptors with an unchanged ligand-binding affinity.
The AII-induced intracellular Ca 2 + transients were moderately reduced in FIPP, YIAP, YAAP and YIPA FLAG-AT 1 receptors and significantly reduced in YIAA, YAAA and FAAA FLAG-AT 1 receptors. Thus, the AII-induced intracellular Ca 2 + transients were also decreased in those mutant receptors in which 125 I-AII binding was decreased. In addition, because GTPgS inhibited the binding of 125 I-AII to the YAAP and 319STOP AT 1 receptors as well as to WT receptors, the YIPP motif may not be involved in coupling to G-protein. Interestingly, since the YIPP motif of the AT 1 receptor is located in the intracellular region, it is difficult to think of mutations of this motif having a direct effect on AII binding to the receptor.
Daviet et al. [27] identified a novel protein, ATRAP, that interacted with the C-terminal region of the AT 1A receptor to reduce AII-induced IP 3 production. This suggests that the Cterminal region of this receptor may have many functions, although the details have not yet been elucidated. Recently, AbdAlla et al. [13] demonstrated that the human AT 1 receptor and bradykinin B 2 receptor can form stable heterodimers and that the heterodimerization enhances AT 1 -receptor signalling. They also showed that AT 1 -B 2 receptor heterodimerization contributed to AII hypersensitivity in preeclampsia [28] . In addition, the rat AT 2 receptor can form a dimer with the AT 1 receptor to antagonize AT 1 receptor signaling [29] . Thus, the AT 1 receptor may physically associate with other receptors or intracellular proteins. We speculate that some mechanisms operating via the YIPP motif may regulate the binding of ligand to the receptor. This is an area that should repay further study and indeed, to test our tentative hypothesis, we are now screening proteins using a two-hybrid system.
In the present study, we investigated the regulation of AII-binding by the YIPP motif located in the C-terminal region of the AT 1 receptor. We confirmed that the YIPP motif is related to AII-binding and, although the mechanism was not made clear, our results may pave the way for an elucidation of the functions of the AT 1 receptor.
Although we have not yet confirmed how the YIPP motif is involved in the physiological effects of the AT 1 receptors (e.g. vasoconstriction and cellular proliferation), our results should help to clarify the mechanism involved in AT 1 receptor-ligand binding. This is an area which will require further study.
